AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.740
-0.060 (-1.25%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 171 | 31 | 41 | 609 | 185 | - | |
| Market Cap Growth | 368.48% | -24.24% | -93.23% | 229.57% | - | - | |
| Enterprise Value | 113 | -31 | -52 | 486 | 81 | - | |
| Last Close Price | 4.74 | 1.14 | 1.38 | 20.49 | 9.53 | - | |
| PB Ratio | 2.45 | 0.59 | 0.50 | 4.89 | 1.94 | - | |
| P/TBV Ratio | 3.22 | 0.59 | 0.50 | 4.89 | 1.94 | - | |
| Debt / Equity Ratio | - | - | - | - | 0.00 | - | |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -1.02 | -0.86 | -1.01 | -0.95 | |
| Quick Ratio | 6.76 | 6.76 | 8.20 | 7.74 | 13.37 | 17.25 | |
| Current Ratio | 6.87 | 6.87 | 8.43 | 7.87 | 13.72 | 17.70 | |
| Return on Equity (ROE) | -52.14% | -52.14% | -49.69% | -58.83% | -52.08% | -66.64% | |
| Return on Assets (ROA) | -30.93% | -30.93% | -29.54% | -36.07% | -31.47% | -38.77% | |
| Return on Capital Employed (ROCE) | -71.60% | -71.60% | -66.70% | -55.80% | -44.30% | -34.80% | |
| Earnings Yield | -20.62% | -112.60% | -124.47% | -10.62% | -22.15% | - | |
| Buyback Yield / Dilution | -1.30% | -1.30% | -26.39% | -53.85% | -481.46% | -2.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.